source
- Data show international medical graduates are not displacing U.S. doctors in 2026 residency matchThe opinion piece examines a social‑media narrative that International Medical Graduates (IMGs) are taking residency slots away from U.S. medical graduates. The authors cite the 2026 Main Residenc…
- Chiesi to acquire KalVista for $1.9 billion, adding hereditary angioedema pill to rare-disease portfolioItalian pharmaceutical group Chiesi announced it will purchase KalVista Therapeutics for $1.9 billion. The transaction values KalVista at $27 per share, a 40 percent premium to its last closing pri…